Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
A new treatment, called NDI-101150 has been shown to be [...]
A new vaccine is being heralded as a 'game changer’ [...]
Surgery (partial or radical nephrectomy) is the standard of care [...]
The final survival information from the phase 3 CLEAR study [...]
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
Further follow-up data from the phase 3 CLEAR study with [...]